Company Filing History:

32 out of 1,323

G.d. Searle & Company

patents

3 out of 200

Pharmacia Corporation

5. 9 out of 832,680

Other

patents

Years Active: 1992-2006

Loading Chart...

46 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 7091319 - IL-3 variant hematopoiesis fusion protein (2006-08-15),

2. 6916800 - Combination therapy including a matrix metalloproteinase inhibitor and an antineoplastic agent (2005-07-12),

3. 6858598 - Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia (2005-02-22),

4. 6833373 - Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia (2004-12-21),

5. 6730303 - Fused G-CSF and IL-3 proteins and uses thereof (2004-05-04),

6. 6689787 - Method of using an integrin antagonist and radiation therapy as combination therapy in the treatment of neoplasia (2004-02-10),

7. 6649645 - Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia (2003-11-18),

8. 6479261 - Methods of using interleukin-3 (IL-3) mutant polypeptides for ex-vivo expansion of hematopoietic stem cells (2002-11-12),

9. 6458931 - Interleukin-3 (IL-3) multiple mutation polypeptides (2002-10-01),

10. 6451852 - Phenylacetonitrilealkylaminoalkyl-ortho-substituted aryl compounds as immunosuppressives (2002-09-17),

11. 6440407 - Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 (IL-3) multiple mutation polypeptides (2002-08-27),

12. 6436387 - Methods of ex-vivo expansion of hematopoietic cells using multivariant IL-3 hematopoiesis chimera proteins (2002-08-20),

13. 6413509 - Methods of ex-vivo expansion of hematopoietic cells using interleukin-3 mutant polypeptides with other hematopoietic growth factors (2002-07-02),

14. 6403076 - Compositions for increasing hematopoiesis with interleukin-3 mutants (2002-06-11),

15. 6379662 - Co-administration of interleukin-3 mutant polypeptides with CSF's for multi-lineage hematopoietic cell production (2002-04-30),

Title: The Inventive Journey of John Patrick McKearn

Introduction: John Patrick McKearn, a prolific inventor hailing from Glencoe, MO, has made significant contributions to the field of biotechnology. With an impressive portfolio of 46 patents under his belt, McKearn's innovative spirit is truly commendable.

Latest Patents: Among McKearn's latest patents is the IL-3 variant hematopoiesis fusion protein. This groundbreaking invention involves fusion molecules consisting of human interleukin-3 (hIL-3) variant proteins functionally linked to a second colony-stimulating factor. Additionally, his patent on combination therapy utilizing a matrix metalloproteinase inhibitor alongside an antineoplastic agent showcases his dedication to advancing effective treatment strategies for neoplasia disorders.

Career Highlights: McKearn's career trajectory includes a tenure at G.D. Searle & Company, where his inventive prowess shone bright. His innovative work in the realm of biotechnology has garnered recognition and praise from peers and industry experts alike, solidifying his reputation as a trailblazer in the field.

Collaborations: Throughout his career, McKearn has collaborated with esteemed professionals such as Barbara Kure Klein and Sarah Ruth Braford-Goldberg. These fruitful collaborations have not only enriched his inventive journey but have also paved the way for groundbreaking advancements in biotechnology.

Conclusion: In conclusion, John Patrick McKearn's remarkable journey as an inventor underscores his unwavering commitment to innovation in biotechnology. His array of patents, career milestones, and collaborations are a testament to his profound impact on the field. McKearn's legacy will undoubtedly continue to inspire future generations of inventors to push the boundaries of what is possible in the realm of biotechnological innovation.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.